author-photo

Saleem A. Farooqui

Pfizer

2

Papers

1

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program.

2021 American Journal of Clinical Dermatology
Show All
- Source
- Cite
- Save
Citations (1)
Correction to: Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program (American Journal of Clinical Dermatology, (2021), 22, 5, (693-707), 10.1007/s40257-021-00618-3)

2021 American Journal of Clinical Dermatology
Show All
- Source
- Cite
- Save
Citations (0)